Filter By Industry
Filter By Tag

Newsroom

Viva BioInnovator Press releases

1 - 1 of 1 Press Release

Arthrosi Therapeutics Forges Ahead with a New Generation of Gout Treatment in Phase 2 Trials
Sep 03, 2019
Arthrosi Therapeutics, a clinical-stage biopharmaceutical company focused on developing a best-in-class treatment for gout, is in the midst of their Phase 2a clinical trial.


Viva BioInnovator RSS Feed